BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15087062)

  • 1. Myelodysplastic syndrome: from morphology to biology.
    Albitar M; Zhou W; Giles F
    Curr Hematol Rep; 2004 May; 3(3):159-64. PubMed ID: 15087062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-induced cytopenia: bone marrow failure syndrome.
    Kondo Y; Molldrem JJ
    Curr Hematol Rep; 2004 May; 3(3):178-83. PubMed ID: 15087065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis in the myelodysplastic syndromes.
    Westwood NB; Mufti GJ
    Curr Hematol Rep; 2003 May; 2(3):186-92. PubMed ID: 12901339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New agents in myelodysplastic syndromes.
    Jabbour EJ; Giles FJ
    Curr Hematol Rep; 2005 May; 4(3):191-9. PubMed ID: 15865871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of angiogenesis in the biology and therapy of myelodysplastic syndromes.
    Aguayo A
    Curr Hematol Rep; 2004 May; 3(3):184-91. PubMed ID: 15087066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
    Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
    Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphology and classification of myelodysplastic syndromes.
    Kouides PA; Bennett JM
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):485-99. PubMed ID: 1613002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired clonogenic growth of myelodysplastic bone marrow progenitors in vitro is irrelevant to their apoptotic state.
    Michalopoulou S; Micheva I; Kouraklis-Symeonidis A; Kakagianni T; Symeonidis A; Zoumbos NC
    Leuk Res; 2004 Aug; 28(8):805-12. PubMed ID: 15203278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The myelodysplastic syndrome I. Pathogenesis, clinical symptoms, diagnosis and differential diagnosis].
    Hasselbalch HC; Juhl BR; Hansen PB
    Ugeskr Laeger; 2002 Jan; 164(4):476-9. PubMed ID: 11838417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
    Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between phenotypic features of blasts and the blast percentage in bone marrow of patients with myelodysplastic syndromes.
    Ogata K; Satoh C; Hyodo H; Tamura H; Dan K; Yoshida Y
    Leuk Res; 2004 Nov; 28(11):1171-5. PubMed ID: 15380341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study.
    Aktas D; Tuncbilek E
    Cancer Genet Cytogenet; 2006 Nov; 171(1):72-5. PubMed ID: 17074595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low blast count myeloid disorders with Auer rods: a clinicopathologic analysis of 9 cases.
    Willis MS; McKenna RW; Peterson LC; Coad JE; Kroft SH
    Am J Clin Pathol; 2005 Aug; 124(2):191-8. PubMed ID: 16040288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome.
    Amin HM; Jilani I; Estey EH; Keating MJ; Dey AL; Manshouri T; Kantarjian HM; Estrov Z; Cortes JE; Thomas DA; Giles FJ; Albitar M
    Blood; 2003 Sep; 102(5):1866-8. PubMed ID: 12730116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The biology of myelodysplastic syndromes].
    Varga G; Uher F
    Orv Hetil; 2004 May; 145(22):1163-70. PubMed ID: 15279403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased apoptosis of circulating T cells in myelodysplastic syndromes.
    Shioi Y; Tamura H; Yokose N; Satoh C; Dan K; Ogata K
    Leuk Res; 2007 Dec; 31(12):1641-8. PubMed ID: 17485109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
    Mufti GJ; Bennett JM; Goasguen J; Bain BJ; Baumann I; Brunning R; Cazzola M; Fenaux P; Germing U; Hellström-Lindberg E; Jinnai I; Manabe A; Matsuda A; Niemeyer CM; Sanz G; Tomonaga M; Vallespi T; Yoshimi A;
    Haematologica; 2008 Nov; 93(11):1712-7. PubMed ID: 18838480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.